Strategies to Account for Design Misspecifications in Randomized Controlled Trials.
NEJM Evid
; 1(4): EVIDe2200012, 2022 Apr.
Article
en En
| MEDLINE
| ID: mdl-38319209
ABSTRACT
Mortality rates of infants (younger than 1 year of age) and neonates (younger than 1 month of age) remain unacceptably high in some geographic regions.1,2 After the first week of life, infection is a significant cause of neonatal and postneonatal mortality.3,4 Biannual mass azithromycin administration has been shown to reduce all-cause childhood mortality by as much as 25% among infants 1 to 5 months of age in Niger.5.
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
NEJM Evid
Año:
2022
Tipo del documento:
Article